Cabot Dividend Investor Weekly Update
New highs are good. Nine portfolio positions are at or near the 52-week high. Let’s be happy.
Read More
company stocks Archives
Cabot Undervalued Stocks Advisor Weekly Update
We’re watching with wonder how Tesla is now a $1 trillion company and that Elon Musk, by himself, is worth more than all of ExxonMobil. There is some poetic irony that the pioneer of electric vehicles and solar panels is outshining (no pun the...
Read More
Cabot Stock of the Week 371
Long-term market trends remain positive andm after the recent strength, short-term trends are back on the positive side as well, so I’m happy (once again) to be advising that you be heavily invested in stocks that meet your investing goals.
Read More
Cabot Small-Cap Confidential Weekly Update
As we move closer to earnings season for our portfolio holdings (really gets underway the week after next) we see many small-cap growth names (and growth stocks in general) recovering nicely from the drawdowns in late September.
Read More
Cabot Dividend Investor Weekly Update
Forget the virus. Forget about the Fed tightening. It’s all about earnings now.
Read More
Cabot Early Opportunities 126
Stock Name
Market Cap
Price
Investment Type
AppLovin’ (APP)
$35.6 billion
95.7
Rapid Growth - Software
Dynatrace (DT)
$21.9 billion
77.0
Rapid Growth – Software
GFL Environmental (GFL)
$14.5 billion
40.1
Rapid Growth – Waste Management
SiteOne Landscape (SITE)
$9.53 billion
214
Growth – Landscape Supply
ZoomInfo (ZI)
$27.3 billion
69.6
Rapid Growth – Software
It’s All About Earnings
There are a lot of things investors could focus these...
Read More
Cabot Undervalued Stocks Advisor Weekly Update
A few weeks ago, at the annual Morningstar Investment Conference in Chicago, two investing icons debated the merits of value versus growth. On the value side was Rob Arnott, founder and head of Research Affiliates, with Cathie Wood, founder and head of ARK Management,...
Read More
Cabot Income Advisor Weekly Update
It was a rough September in the market. But so far, October is making up for it.
Read More
Cabot Stock of the Week 370
Long-term market trends remain positive, but short-term trends remain troubling. Still, growth stocks snapped back strongly last week, so it’s possible the weakness has passed and the market will become more cohesive and begin a renewed advance.
Read More
Cabot Small-Cap Confidential Weekly Update
The biggest stories this week weren’t all that different from last week, namely supply chains, interest rates/inflation, and Covid. But this week has a decidedly different feel to it, possibly because we’ve added earnings season into the mix and, so far, that’s going well...
Read More
Cabot Income Advisor Weekly Update
So far, October looks better than September for the market. After falling 4.8% in September, the worst month since the pandemic recovery began, the S&P 500 is up slightly for October.
Read More
Cabot Undervalued Stocks Advisor Weekly Update
Last week, we wrote about how lower quality, in both home appliances and tangible money, debases value and is a form of inflation. Today’s note includes some of our current views on inflation and capital markets, and what investors can do to help inflation’s...
Read More
Cabot Micro-Cap Insider 1021
Time for a Rocket
This week, I was tempted to recommend another cyclical energy name as I tend to believe we are in the early innings of an energy crisis.
Soaring commodity prices and low equity valuations should result in some explosive returns. But we have...
Read More
Cabot Dividend Investor 1021
As financial markets have grown in sophistication, private equity investing is no longer the exclusive domain of the wealthy.
Read More
Cabot Stock of the Week 369
Long-term market trends remain positive, but short-term trends have become troubling in recent weeks (last week we sold three stocks), so I’m now recommending scaling back on your market exposure.
Read More
Cabot Small Cap Confidential 269
The Big Idea
If given a choice between taking a drug via pill or needle, how often would you choose the needle?
If you said never, congrats. You’re human.
Nobody in their right mind says, “I’ll just take the shot doc.” Unfortunately, there are still tons medications...
Read More
Cabot Dividend Investor Weekly Update
So far, October has been volatile. There have been strong rallies that quickly become undone in the following days. The market is still even for the month, but it looks very unsteady.
Read More
Cabot Undervalued Stocks Advisor 1021
In the olden days, when kings and governments minted coins made of gold and silver, people were tempted to shave tiny amounts off the edges of the coins, thus stealing some value for themselves.
Read More
Cabot Income Advisor Weekly Update
September lived up to its bad reputation. The S&P 500 fell 4.8% for the month. But September is over. Now it’s October, which is historically only the second-worst month of the year. What now?
Read More
Cabot Stock of the Week 368
Today’s recommendation is an established retailer with a stable of familiar names—and it pays a dividend!
Read More